卖什么
Software to launch and integrate genetics into clinical care
商业模式拆解
买家：谁掌握预算？
未核实Health systems and clinics running genetic services or precision medicine programs (clinical leaders and genetic services directors).
触发点：什么让他们现在购买？
Too few eligible patients get genetic testing and manual referral, consent and ordering workflows are slow; the site claims 40 days saved from referral to results.
工作流：什么输入变成什么输出？
Identify eligible patients from EMR or patient-reported data, send education and consent, order from the lab of choice, return results and decision support into the EHR, then track program outcomes.
经济账：省了什么，怎么收费？
Software sold to healthcare organizations; the ROI calculator projects revenue opportunity from recommended medical management changes (e.g. $1,392,000 for an example patient volume).
渠道：怎么接触到客户？
Demo-led enterprise sales (Request a Demo), integrates with major EHRs via SMART on FHIR and with multiple labs.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2022 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.